SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e3e924854294e17bd2cd16091505acc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4e3e924854294e17bd2cd16091505acc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4e3e924854294e17bd2cd16091505acc2021-12-02T11:44:50ZSUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis10.1038/s41467-021-22163-72041-1723https://doaj.org/article/4e3e924854294e17bd2cd16091505acc2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22163-7https://doaj.org/toc/2041-1723The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer.Xun ShangguanJianli HeZehua MaWeiwei zhangYiyi JiKai ShenZhiying YueWenyu LiZhixiang XinQuan ZhengYing CaoJiahua PanBaijun DongJinke ChengQi WangWei XueNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Xun Shangguan Jianli He Zehua Ma Weiwei zhang Yiyi Ji Kai Shen Zhiying Yue Wenyu Li Zhixiang Xin Quan Zheng Ying Cao Jiahua Pan Baijun Dong Jinke Cheng Qi Wang Wei Xue SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
description |
The oncogenic activity of Hexokinase 2, the first rate-limiting enzyme of glycolysis, requires its mitochondrial localization. Here, the authors show that SUMOylation of hexokinase 2 disrupts its binding to mitochondria and protects cells from tumorigenesis in prostate cancer. |
format |
article |
author |
Xun Shangguan Jianli He Zehua Ma Weiwei zhang Yiyi Ji Kai Shen Zhiying Yue Wenyu Li Zhixiang Xin Quan Zheng Ying Cao Jiahua Pan Baijun Dong Jinke Cheng Qi Wang Wei Xue |
author_facet |
Xun Shangguan Jianli He Zehua Ma Weiwei zhang Yiyi Ji Kai Shen Zhiying Yue Wenyu Li Zhixiang Xin Quan Zheng Ying Cao Jiahua Pan Baijun Dong Jinke Cheng Qi Wang Wei Xue |
author_sort |
Xun Shangguan |
title |
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
title_short |
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
title_full |
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
title_fullStr |
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
title_full_unstemmed |
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
title_sort |
sumoylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/4e3e924854294e17bd2cd16091505acc |
work_keys_str_mv |
AT xunshangguan sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT jianlihe sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT zehuama sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT weiweizhang sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT yiyiji sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT kaishen sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT zhiyingyue sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT wenyuli sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT zhixiangxin sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT quanzheng sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT yingcao sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT jiahuapan sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT baijundong sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT jinkecheng sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT qiwang sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis AT weixue sumoylationcontrolsthebindingofhexokinase2tomitochondriaandprotectsagainstprostatecancertumorigenesis |
_version_ |
1718395279336538112 |